Sort
172,184 grants matching “inflammation”
Activities Of Chemokines In Health and Disease
$1,791,192Joshua M Farber · National Institute Of Allergy And Infectious Diseases · ZIA · FY2025 · AI
Elafin Therapy for Pulmonary Arterial Hypertension
$1,790,971Marlene Rabinovitch · Stanford University · P01 · FY2017 · HL
AtRial Cardiopathy and Antithrombotic Drugs In prevention After cryptogenicstroke (ARCADIA)
$1,790,846Mitchell S Elkind · Columbia University Health Sciences · U01 · FY2021 · NS
EGR1 REGULATION OF NEURONAL SURVIVAL AND INFLAMMATION FOLLOWING VEEV INFECTION.
$1,790,795Virginia Polytechnic Institute & State University · · FY2025 · Defense Threat Reduction Agency
Specialized Center for Oral Inflammation and Resolution
$1,790,664Charles Nicholas Serhan · Brigham And Women'S Hospital · P50 · FY2007 · DE
Specialized Center for Oral Inflammation and Resolution
$1,790,664Charles Nicholas Serhan · Brigham And Women'S Hospital · P50 · FY2008 · DE
Collagen-related diseases
$1,790,328Sergey Leikin · Eunice Kennedy Shriver National Institute Of Child Health & Human Development · ZIA · FY2025 · HD
Targeting the PD - 1 pathway to eradicate SIV/HIV
$1,790,318Rafick-Pierre Sekaly · University Of California, San Francisco · U19 · FY2015 · AI
Circumventing barriers to effective oncolytic virotherapy of malignant gliomas
$1,789,540E. Antonio Chiocca · Brigham And Women'S Hospital · P01 · FY2021 · CA
Genetic Factors to Oral Health Disparities in Appalachia
$1,789,023Mary L Marazita · University Of Pittsburgh At Pittsburgh · R01 · FY2007 · DE
GENE THERAPY FOR CYSTIC FIBROSIS
$1,789,000Weill Medical College Of Cornell Univ · P01 · FY2000 · HL
Clarifying the Optimal Application of SLT Therapy (COAST) Trial
$1,788,630Stephen R Wisniewski · University Of Pittsburgh At Pittsburgh · UG1 · FY2020 · EY
Gene therapy for Alzheimer's disease using virally delivered Aβ variants
$1,788,342Joanna L Jankowsky · Baylor College Of Medicine · RF1 · FY2021 · AG
Mechanism Of Action And Functions Of The Gli-related Proteins Glis 1-3
$1,788,201Anton M Jetten · National Institute Of Environmental Health Sciences · ZIA · FY2020 · ES
TARGETING TRYPSIN-INFLAMMATION AXIS FOR PANCREATITIS THERAPY IN A HUMANIZED PANCREATITIS MODEL
$1,787,667Mayo Clinic Jacksonville (A Nonprofit Corporation) · · FY2015 · Department of the Army
Trial of Late SURFactant (TOLSURF) to Prevent BPD - Clinical Coord Ctr
$1,787,395Roberta Anderson Ballard · University Of California, San Francisco · U01 · FY2009 · HL
Pathophysiologic and therapeutic mechanisms of aspirin exacerbated respiratory d*
$1,787,094Joshua A Boyce · Brigham And Women'S Hospital · U19 · FY2012 · AI
CELLULAR BIOLOGY OF RENAL FUNCTION AND DISEASE
$1,787,088Dennis Brown · Massachusetts General Hospital · P01 · FY2011 · DK
ARTERIAL DYSFUNCTION--BASIC AND CLINICAL MECHANISMS
$1,786,946Brigham And Women'S Hospital · P01 · FY2003 · HL
New therapies for liver fibrosis and hyperproliferation in alpha1-AT deficiency
$1,786,840David H Perlmutter · University Of Pittsburgh At Pittsburgh · P01 · FY2013 · DK
Molecular Basis of Lung Morphogenesis Injury & Repair
$1,786,791David Warburton · Children'S Hospital Of Los Angeles · P01 · FY2006 · HL
Defining Molecular Phenotypes of Exacerbation Prone Asthmatics
$1,786,716Max A Seibold · National Jewish Health · P01 · FY2020 · HL
Defining Molecular Phenotypes of Exacerbation Prone Asthmatics
$1,786,716Dennis R Voelker · National Jewish Health · P01 · FY2019 · HL
IL-2IL-15 Cytokine Receptor: Implications for Cancer Therapy and Vaccine Design
$1,786,679Thomas Waldmann · Division Of Clinical Sciences - Nci · ZIA · FY2009 · CA
Integrated Molecular Profiling of Diabetic Retinopathy
$1,786,652Vinit B Mahajan · Stanford University · R01 · FY2025 · EY